Sa Wang MD

Dr. Sa Wang is a professor of pathology and the section chief of flow cytometry in the Department of Hematopathology, The University of Texas MD Anderson Cancer Center. Dr. Wang’s clinical expertise and research interest are in hematolymphoid neoplasms including the use of histopathology, flow cytometry, and molecular genetics for disease diagnosis, classification, and risk stratification. Dr. Wang has published over 290 original studies, 33 review articles, and 25 book chapters for 7 reference books, an editor and author for “Diagnosis of Blood and Bone Marrow Disorders”.

Dr. Wang is an associate editor for Cytometry B Clinical Cytometry, a council member, and currently the vice president of the International Clinical Cytometry Society. Dr. Wang has taught or directed many CME courses and served as organizer, moderator, panelist, or session chair at various meetings and workshops sponsored by USCAP, CAP, ASCP, ICCS, IAP, AMLI, SH-EAH, and EH, etc, and an invited speaker at many institutions. Dr. Wang has participated in the writing of practice guidelines for acute leukemia diagnosis as a joint effort by the CAP and ASH. Dr. Wang is one of the session chairs for the recent International Consensus Classification (ICC) of hematolymphoid neoplasms, and a member of the AML MRD and MDS flow cytometry ELN groups. Dr. Wang has obtained multiple industrial funds to study tumor biomarkers.